SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-014836
Filing Date
2014-03-11
Accepted
2014-03-11 16:19:27
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v369831_10k.htm 10-K 2890197
2 EXHIBIT 3.3 v369831_ex3-3.htm EX-3.3 131132
3 EXHIBIT 23.1 v369831_ex23-1.htm EX-23.1 6624
4 EXHIBIT 23.2 v369831_ex23-2.htm EX-23.2 3413
5 EXHIBIT 31.1 v369831_ex31-1.htm EX-31.1 10854
6 EXHIBIT 31.2 v369831_ex31-2.htm EX-31.2 10846
7 EXHIBIT 32.1 v369831_ex32-1.htm EX-32.1 5320
8 EXHIBIT 32.2 v369831_ex32-2.htm EX-32.2 5076
  Complete submission text file 0001144204-14-014836.txt   10157009

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT chtp-20131231.xml EX-101.INS 1213174
10 XBRL TAXONOMY EXTENSION SCHEMA chtp-20131231.xsd EX-101.SCH 69594
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20131231_cal.xml EX-101.CAL 39034
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20131231_def.xml EX-101.DEF 312314
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20131231_lab.xml EX-101.LAB 406405
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20131231_pre.xml EX-101.PRE 361106
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 14684477
SIC: 2836 Biological Products, (No Diagnostic Substances)